Loss of CDC4/FBXW7 in gastric carinoma

Cellular Oncology

Volumn 32, Issue 5-6, 2010, Pages 347-359

  Milne, A N ^a   Leguit, R ^a   Corver, W E ^b   Morsink, F H M ^a   Polak, M ^c   De Leng, W W ^a   Carvalho, R ^d   Offerhaus, G J A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d ZF Screens BV ^*  (Netherlands)

Author keywords

early onset gastric cancer; FBXW7; Gastric cancer; hcdc4; MLPA

Indexed keywords

CYCLIN DEPENDENT KINASE 4; CYCLIN E; NOTCH RECEPTOR; PROTEIN C JUN;

ARTICLE; CARCINOMA CELL; FBXW7 GENE; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; ONCOGENE C MYC; PLOIDY; PRIORITY JOURNAL; SEQUENCE ANALYSIS; STOMACH CANCER; TISSUE MICROARRAY; TUMOR GENE;

CARCINOMA; CELL CYCLE PROTEINS; CELL SEPARATION; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOMES, HUMAN, PAIR 4; DNA MUTATIONAL ANALYSIS; F-BOX PROTEINS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC ASSOCIATION STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LOSS OF HETEROZYGOSITY; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS C-MYC; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED; UBIQUITIN-PROTEIN LIGASES;

EID: 77953984794     PISSN: 15705870     EISSN: None     Source Type: Journal    
DOI: 10.3233/CLO-2010-523     Document Type: Article

References (55)

1. S. Adhikary and M. Eilers, Transcriptional regulation and transformation by Myc proteins, Nat. Rev. Mol. Cell Biol. 6 (2005), 635-645.
2. S. Akhoondi, D. Sun, N. von der Lehr, S. Apostolidou, K. Klotz, A. Maljukova et al., FBXW7/hCDC4 is a general tumor suppressor in human cancer, Cancer Res. 67 (2007), 9006-9012.
3. E.S. Calhoun, J.B. Jones, R. Ashfaq, V. Adsay, S.J. Baker, V. Valentine et al., BRAF and FBXW7 (CDC4, FBW7, AGO, SEL10) mutations in distinct subsets of pancreatic cancer: potential therapeutic targets, Am. J. Pathol. 163 (2003), 1255-1260.
4. R. Carvalho, A.N. Milne, M. Polak, W.E. Corver, G.J. Offer-haus and M.A. Weterman, Exclusion of RUNX3 as a tumour-suppressor gene in early-onset gastric carcinomas, Oncogene 24 (2005), 8252-8258.
5. R. Carvalho, A.N. Milne, M. Polak, G.J. Offerhaus and M.A. Weterman, A novel region of amplification at 11p12-13 in gastric cancer, revealed by representational difference analysis, is associated with overexpression of CD44v6, especially in early-onset gastric carcinomas, Genes Chromosomes Cancer 45 (2006), 967-975.
6. R. Carvalho, A.N. Milne, B.P. Van Rees, E. Caspers, L. Cirnes, C. Figueiredo et al., Early-onset gastric carcinomas display molecular characteristics distinct from gastric carcinomas occurring at a later age, J. Pathol. 204 (2004), 75-83.
7. R. Cassia, G. Moreno-Bueno, S. Rodriguez-Perales, D. Hardis-son, J.C. Cigudosa and J. Palacios, Cyclin E gene (CCNE) amplification and hCDC4 mutations in endometrial carcinoma, J. Pathol. 201 (2003), 589-595.
8. J. Coffa, M.A. van de Wiel, B. Diosdado, B. Carvalho, J. Schouten and G.A. Meijer, MLPAnalyzer: data analysis tool for reliable automated normalization of MLPA fragment data, Cell Oncol. 30 (2008), 323-335.
9. P. Correa and Y.H. Shiao, Phenotypic and genotypic events in gastric carcinogenesis, Cancer Res. 54 (1994), 1941-1943.
10. W.E. Corver, N.T. Ter Haar, E.J. Dreef, N.F. Miranda, F.A. Prins, E.S. Jordanova et al., High-resolution multi-parameter DNA flow cytometry enables detection of tumour and stromal cell subpopulations in paraffin-embedded tissues, J. Pathol. 206 (2005), 233-241.
11. S. Ekholm-Reed, C.H. Spruck, O. Sangfelt, F. van Drogen, E. Mueller-Holzner, M. Widschwendter et al., Mutation of hCDC4 leads to cell cycle deregulation of cyclin E in cancer, Cancer Res. 64 (2004), 795-800.
12. D. Forman, D.G. Newell, F. Fullerton, J.W. Yarnell, A.R. Stacey, N. Wald and F. Sitas, Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation, BMJ 302 (1991), 1302-1305.
13. P. Guilford, J. Hopkins, J. Harraway, M. McLeod, N. McLeod, P. Harawira et al., E-cadherin germline mutations in familial gastric cancer, Nature 392 (1998), 402-405.
14. S. Han, H.Y. Kim, K. Park, H.J. Cho, M.S. Lee, H.J. Kim and Y.D. Kim, c-Myc expression is related with cell proliferation and associated with poor clinical outcome in human gastric cancer, J. Korean Med. Sci. 14 (1999), 526-530.
15. T. Hara, A. Ooi, M. Kobayashi, M. Mai, K. Yanagihara and I. Nakanishi, Amplification of c-myc, K-sam and c-met in gastric cancers: detection by fluorescence in situ hybridization, Lab. Invest. 78 (1998), 1143-1153.
16. M.M. Hubalek, A. Widschwendter, M. Erdel, A. Gschwendt-ner, H.M. Fiegl, H.M. Muller et al., Cyclin E dysregulation and chromosomal instability in endometrial cancer, Oncogene 23 (2004), 4187-4192.
17. Z. Kemp, A. Rowan, W. Chambers, N. Wortham, S. Halford, O. Sieber et al., CDC4 mutations occur in a subset of colorectal cancers but are not predicted to cause loss of function and are not associated with chromosomal instability, Cancer Res. 65 (2005), 11361-11366.
18. Y.H. Kim, N.G. Kim, J.G. Lim, C. Park and H. Kim, Chromosomal alterations in paired gastric adenomas and carcinomas, Am. J. Pathol. 158 (2001), 655-662.
19. T. Kimura, M. Gotoh, Y. Nakamura and H. Arakawa, hCDC4b, a regulator of cyclin E, as a direct transcriptional target of p53, Cancer Sci. 94 (2003), 431-436.
20. Y. Kimura, T. Noguchi, K. Kawahara, K. Kashima, T. Daa and S. Yokoyama, Genetic alterations in 102 primary gastric cancers by comparative genomic hybridization: gain of 20q and loss of 18q are associated with tumor progression, Mod. Pathol. 17 (2004), 1328-1337.
21. S. Knuutila, Y. Aalto, K. Autio, A.M. Bjorkqvist, W. El-Rifai, S. Hemmer et al., DNA copy number losses in human neoplasms, Am. J. Pathol. 155 (1999), 683-694. (Pubitemid 29426813)
22. J. Kononen, L. Bubendorf, A. Kallioniemi, M. Barlund, P. Schraml, S. Leighton et al., Tissue microarrays for high-throughput molecular profiling of tumor specimens, Nat. Med. 4 (1998), 844-847.
23. P. Laurén, The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification, Acta Pathol. Microbiol. Scand. 64 (1965), 31-49.
24. J.W. Lee, Y.H. Soung, H.J. Kim, W.S. Park, S.W. Nam, S.H. Kim et al., Mutational analysis of the hCDC4 gene in gastric carcinomas, Eur. J. Cancer 42 (2006), 2369-2373.
25. J.H. Mao, J. Perez-Losada, D. Wu, R. Delrosario, R. Tsune-matsu, K.I. Nakayama et al., Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene, Nature 432 (2004), 775-779.
26. A.N. Milne, F. Carneiro, C. O'Morain and G.J. Offerhaus, Nature meets nurture: molecular genetics of gastric cancer, Hum. Genet. 126 (2009), 615-628.
27. A.N. Milne, R. Carvalho, M. Jansen, E.K. Kranenbarg, C.J. van de Velde, F.M. Morsink et al., Cyclin E low molecular weight isoforms occur commonly in early-onset gastric cancer and independently predict survival, J. Clin. Pathol. 61 (2008), 311-316.
28. A.N. Milne, R. Carvalho, F.M. Morsink, A.R. Musler, W.W. de Leng, A. Ristimaki and G.J. Offerhaus, Early-onset gastric cancers have a different molecular expression profile than conventional gastric cancers, Mod. Pathol. 19 (2006), 564-572.
29. A.N. Milne, R. Sitarz, R. Carvalho, F. Carneiro and G.J. Of-ferhaus, Early onset gastric cancer: on the road to unraveling gastric carcinogenesis, Curr. Mol. Med. 7 (2007), 15-28.
30. A.N. Milne, R. Sitarz, R. Carvalho, M.M. Polak, M. Ligten-berg, P. Pauwels et al., Molecular analysis of primary gastric cancer, corresponding xenografts, and 2 novel gastric carcinoma cell lines reveals novel alterations in gastric carcinogen-esis, Hum. Pathol. 38 (2007), 903-913.
31. K.H. Moberg, D.W. Bell, D.C. Wahrer, D.A. Haber and I.K. Hariharan, Archipelago regulates Cyclin E levels in Drosophila and is mutated in human cancer cell lines, Nature 413 (2001), 311-316.
32. K.I. Nakayama and K. Nakayama, Regulation of the cell cycle by SCF-type ubiquitin ligases, Semin. Cell Dev. Biol. 16 (2005), 323-333.
33. K.I. Nakayama and K. Nakayama, Ubiquitin ligases: cell-cycle control and cancer, Nat. Rev. Cancer 6 (2006), 369-381.
34. C. Oliveira, R. Seruca and F. Carneiro, Genetics, pathology, and clinics of familial gastric cancer, Int. J. Surg. Pathol. 14 (2006), 21-33.
35. D.M. Parkin, F. Bray, J. Ferlay and P. Pisani, Estimating the world cancer burden: Globocan 2000, Int. J. Cancer 94 (2001), 153-156.
36. J. Parsonnet, G.D. Friedman, D.P. Vandersteen, Y. Chang, J.H. Vogelman, N. Orentreich and R.K. Sibley, Helicobacter pylori infection and the risk of gastric carcinoma, N. Engl. J. Med. 325 (1991), 1127-1131.
37. H. Rajagopalan, P.V. Jallepalli, C. Rago, V.E. Velculescu, K.W. Kinzler, B. Vogelstein and C. Lengauer, Inactivation of hCDC4 can cause chromosomal instability, Nature 428 (2004), 77-81.
38. J.P. Schouten, C.J. McElgunn, R. Waaijer, D. Zwijnenburg, F. Diepvens and G. Pals, Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification, Nucleic. Acids. Res. 30 (2002), e57.
39. R. Sitarz, R.J. Leguit, W.W. de Leng, F.H. Morsink, W.P. Polkowski, R. Maciejewski et al., Cyclooxygenase-2 mediated regulation of E-cadherin occurs in conventional but not early-onset gastric cancer cell lines, Cell Oncol. 31 (2009), 475-485.
40. C.H. Spruck, H. Strohmaier, O. Sangfelt, H.M. Muller, M. Hubalek, E. Muller-Holzner et al., hCDC4 gene mutations in endometrial cancer, Cancer Res. 62 (2002), 4535-4539.
41. C.H. Spruck, K.A. Won and S.I. Reed, Deregulated cyclin E induces chromosome instability, Nature 401 (1999), 297-300.
42. M. Srinivasan, D. Sedmak and S. Jewell, Effect of fixatives and tissue processing on the content and integrity of nucleic acids, Am. J. Pathol. 161 (2002), 1961-1971.
43. H. Strohmaier, C.H. Spruck, P. Kaiser, K.A. Won, O. Sangfelt and S.I. Reed, Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line, Nature 413 (2001), 316-322.
44. R. Sud, D. Wells, I.C. Talbot and J.D. Delhanty, Genetic alterations in gastric cancers from British patients, Cancer Genet. Cytogenet. 126 (2001), 111-119.
45. S.T. Tay, S.H. Leong, K. Yu, A. Aggarwal, S.Y. Tan, C.H. Lee et al., A combined comparative genomic hybridization and expression microarray analysis of gastric cancer reveals novel molecular subtypes, Cancer Res. 63 (2003), 3309-3316.
46. M.T. Tetzlaff, W. Yu, M. Li, P. Zhang, M. Finegold, K. Ma-hon et al., Defective cardiovascular development and elevated cyclin E and Notch proteins in mice lacking the Fbw7 F-box protein, Proc. Natl. Acad. Sci. USA 101 (2004), 3338-3345.
47. R. Tsunematsu, K. Nakayama, Y. Oike, M. Nishiyama, N. Ishida, S. Hatakeyama et al., Mouse Fbw7/Sel-10/Cdc4 is required for notch degradation during vascular development, J. Biol. Chem. 279 (2004), 9417-9423.
48. G.N. van Muijen, D.J. Ruiter and S.O. Warnaar, Coexpression of intermediate filament polypeptides in human fetal and adult tissues, Lab. Invest. 57 (1987), 359-369.
49. B.P. van Rees, E. Caspers, A. zur Hausen, A. van den Brule, P. Drillenburg, M.A. Weterman and G.J. Offerhaus, Different pattern of allelic loss in Epstein-Barr virus-positive gastric cancer with emphasis on the p53 tumor suppressor pathway, Am. J. Pathol. 161 (2002), 1207-1213.
50. A. Varis, B. van Rees, M. Weterman, A. Ristimaki, J. Offerhaus and S. Knuutila, DNA copy number changes in young gastric cancer patients with special reference to chromosome 19, Br. J. Cancer 88 (2003), 1914-1919.
51. M. Welcker, A. Orian, J.E. Grim, R.N. Eisenman and B.E. Clurman, A nucleolar isoform of the Fbw7 ubiquitin ligase regulates c-Myc and cell size, Curr. Biol. 14 (2004), 1852-1857.
52. M. Welcker, A. Orian, J. Jin, J.E. Grim, J.W. Harper, R.N. Eisenman and B.E. Clurman, The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation, Proc. Natl. Acad. Sci. USA 101 (2004), 9085-9090.
53. C. Williams, F. Ponten, C. Moberg, P. Soderkvist, M. Uhlen, J. Ponten et al., A high frequency of sequence alterations is due to formalin fixation of archival specimens, Am. J. Pathol. 155 (1999), 1467-1471.
54. M. Yada, S. Hatakeyama, T. Kamura, M. Nishiyama, R. Tsune-matsu, H. Imaki et al., Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7, EMBO J. 23 (2004), 2116-2125.
55. T. Yokobori, K. Mimori, M. Iwatsuki, H. Ishii, I. Onoyama, T. Fukagawa et al., p53-Altered FBXW7 expression determines poor prognosis in gastric cancer cases, Cancer Res. 69 (2009), 3788-3794.